TrialFind
Saved trials
Back to results
Unknown
Phase 2
Phase 3
Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease
NCT01282619
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China
View on ClinicalTrials.gov
Official details
Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease — TrialFind